NICO Corporation Secures New Patent Approvals Supporting Neurosurgical Brain Access Solutions

NICO Corporation continues steady growth of its patent portfolio with the issuance of two new key patents this week supporting its surgical access system and the system’s assembly and method of use in minimally invasive neurosurgery.

NICO currently holds over 250 issued or pending patents, with 60 focusing solely on safe and repeatable non-disruptive access through eloquent areas of the brain with NICO BrainPath®, efficient removal of tumors and clots down a small corridor using the NICO Myriad®, and collection and biological preservation of tumor tissue in the operating room with the Automated Preservation System®.

“Protecting our intellectual property has always been a top priority for NICO,” said Jim Pearson, president and CEO of NICO Corporation. “Our technologies comprise an integrated systems approach to brain surgery that is creating new realities for neurosurgeons. The published evidence associated with our technologies suggest improved surgical outcomes, giving patients new-found hope.”

Pearson added that these two new patent approvals related to safe access to all regions of the brain are key to protecting the company’s unique and revolutionary intellectual property. “We take IP protection of our innovative technologies very seriously and are proud of our proactive approach to protecting the technical advantages our tools offer neurosurgeons and healthcare providers.”

NICO technologies have been featured in more than 170 peer-reviewed published papers with over 550 unique authors from major academic centers. The company is also the sponsor of ENRICH, a 300-patient $10 million randomized controlled clinical trial that seeks to compare outcomes between minimally invasive early surgical intervention of intracerebral hemorrhage clot removal exclusively using NICO technologies and the current medical management standard of care.

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy